|
ACPL2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.424800E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.265400E-01 |
| Normal-vs-Stage2 |
3.059200E-01 |
| Normal-vs-Stage3 |
5.464600E-01 |
| Normal-vs-Stage4 |
7.508200E-01 |
| Stage1-vs-Stage2 |
6.899400E-01 |
| Stage1-vs-Stage3 |
8.241800E-01 |
| Stage1-vs-Stage4 |
5.404200E-01 |
| Stage2-vs-Stage3 |
6.412400E-01 |
| Stage2-vs-Stage4 |
4.479200E-01 |
| Stage3-vs-Stage4 |
7.613400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.213600E-01 |
| Normal-vs-AfricanAmerican |
7.099200E-01 |
| Normal-vs-Asian |
8.278800E-01 |
| Caucasian-vs-AfricanAmerican |
6.523600E-01 |
| Caucasian-vs-Asian |
8.988000E-01 |
| AfricanAmerican-vs-Asian |
9.579800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.700000E-01 |
| Normal-vs-Female |
2.261600E-01 |
| Male-vs-Female |
4.685000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.660400E-01 |
| Normal-vs-Age(41-60Yrs) |
2.080200E-01 |
| Normal-vs-Age(61-80Yrs) |
4.213200E-01 |
| Normal-vs-Age(81-100Yrs) |
6.119200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.857000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.708200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.148000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.271600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.700800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.918600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.241200E-01 |
| Normal-vs-Grade 2 |
1.663580E-01 |
| Normal-vs-Grade 3 |
3.391800E-01 |
| Normal-vs-Grade 4 |
7.445800E-01 |
| Grade 1-vs-Grade 2 |
8.713000E-01 |
| Grade 1-vs-Grade 3 |
9.910800E-01 |
| Grade 1-vs-Grade 4 |
4.813800E-01 |
| Grade 2-vs-Grade 3 |
6.383200E-01 |
| Grade 2-vs-Grade 4 |
6.360000E-02 |
| Grade 3-vs-Grade 4 |
1.683550E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.006100E-02 |
| Normal-vs-ccB subtype |
9.865200E-01 |
| ccA subtype-vs-ccB subtype |
2.559300E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.839370E-01 |
| Normal-vs-N1 |
7.196600E-01 |
| N0-vs-N1 |
7.305000E-01 |
|
|
